OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Cancer Research and Clinical Oncology is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Therapeutic yield of extensive molecular profiling in cholangiocarcinoma: a retrospective single-center study	199
Heterodimerization of cholecystokinin 1 and cholecystokinin 2 receptors in gallbladder cancer: a new mechanism for carcinogenesis	110
A case of rare metachronous four primary carcinoma	83
A predictive model for patients with local-regionally advanced oropharyngeal squamous cell carcinoma treated after cervical lymph node dissection	79
Clinical characteristics and long-term outcomes of rhabdomyosarcoma in Korean children, adolescents and young adults: a single-center experience	65
Extracellular urinary microRNAs as non-invasive biomarkers of endometrial and ovarian cancer	64
Can whole-body MRI replace CT in management of metastatic testicular cancer? A prospective, non-inferiority study	63
Attitudes toward a COVID-19 vaccine and vaccination status in cancer patients: correspondence	63
Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma	63
GSTM1 and GSTT1 polymorphisms associated with pain in a chemotherapy-induced peripheral neuropathy cohort	61
Introducing a standardized assessment of patients’ interest in and usage of CAM in routine cancer care: chances and risks from patients’ and physicians’ point of view	58
MET overexpression in EGFR L858R mutant treatment-naïve advanced lung adenocarcinoma correlated with poor prognosis: a real-world retrospective study	57
Comment on “Predicting metastasis at initial diagnosis and radiotherapy effectiveness in patients with metastatic osteosarcoma”	54
Hairy cell leukemia: a specific 17-gene expression signature points to new targets for therapy	54
Effects of gross tumor volume and radiation dose on survival and locoregional recurrence in early-stage extranodal NK/T-cell lymphoma treated with intensity-modulated radiation therapy	52
Exportin XPO7 acts as an oncogenic factor in prostate cancer via upregulation of TCF3	48
Early T-cell precursor lymphoblastic leukemia accompanied by prominent blastic plasmacytoid dendritic cell proliferation mimicking blastic plasmacytoid dendritic cell neoplasm: an exceptional case rep	47
Sintilimab with chemotherapy as first-line treatment for locally advanced or metastatic squamous non-small-cell lung cancer: a real-world data study	45
High USP4 mRNA is associated with an HPV-positive status in head and neck squamous cell carcinoma patients	45
A novel antibody-TCR (AbTCR) T-cell therapy is safe and effective against CD19-positive relapsed/refractory B-cell lymphoma	45
Comparison of stereotactic body radiotherapy with and without lenvatinib for advanced hepatocellular carcinoma: a propensity score analysis	43
Relevance of tumor boards for the inclusion of patients in oncological clinical trials	43
Combination of multiple nucleic acid aptamers for precision detection of tumors based on optical methods	42
Comparison of robotic‑assisted versus conventional laparoscopic surgery for mid–low rectal cancer: a systematic review and meta-analysis	40
Breast cancer prediction using different machine learning methods applying multi factors	40

Identifying immune infiltration by deep learning to assess the prognosis of patients with hepatocellular carcinoma	39
Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells	39
Adjuvant radiotherapy in patients with node-positive prostate cancer after radical prostatectomy	38
Prognostic nomogram for external ear melanoma patients in the elderly: a SEER-based study	37
Prognostic value of comprehensive typing based on m6A and gene cluster in TNBC	36
Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo‑)radiotherapy: a systematic review and meta‑analysis. In regard to De Virgilio et al	35
Vitiligo-like leukoderma as an indicator of clinical response to immune checkpoint inhibitors in late-stage melanoma patients	33
Pneumatosis intestinalis in cancer patients who received immune checkpoint inhibitors	33